Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Leuko Labs develops non-invasive white blood cell monitoring device.
DeepCure leverages AI and AI-enabled technologies to advance small molecule discovery techniques.
NLX offers platform for automating customer experiences across channels with advanced AI and language models.
Fantix is an AI platform for privacy-first data science, synthetic data, and predictive analytics.
Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.
Grips Intelligence is a transaction Intelligence platform that delivers valuable insights into how the world buys products online.
Lindy Biosciences is a development-stage protein therapeutic formulations company.
Tethr operates as an AI-powered conversation intelligence platform.
Coagulo Medical Technologies is transforming medicine with the first portable and connected precision-medicine platform.
Obsidio is a medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels.
IAG Capital Partners has invested in 58 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
IAG Capital Partners's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Machine Learning, Product Research. The firm invests across 20 different industry categories.
Among tracked funding rounds, DeepCure received $24.6M in a Series A round. IAG Capital Partners's total known invested capital is $1.3B.
IAG Capital Partners's average investment size is $21.6M across its portfolio of 58 companies.
Recent IAG Capital Partners portfolio additions include Leuko, DeepCure, NLX, Fantix, Lucid Scientific. These companies were founded in 2020 or later.